Condition

Diabetes Type II

ClinicalTrials.gov condition label

Clinical trials9

Recruiting1

Common interventions12

Lead sponsors shown9

Clinical trials

9 shown

Effects of Core Strengthening Exercises With Diapgragmatic Breathing Versus Core Strengthening Exercises With Pilate Breathing in Diabetes Type II PatientsNCT07290231 · 2025-08-06

A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 DiabetesNCT07748208 · 2026-10-30

NOT_YET_RECRUITING

Feasibility Study of DermGEN for Diabetic Foot Ulcer TreatmentNCT02184455 · 2016-07-01

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access InitiativeNCT02773095 · 2016-06-01

Novel Biomarker for Development of T2DNCT02326129 · 2015-02-01

Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care OfficesNCT02361489 · 2015-02-01

The Influence of Health Beliefs and Uncertainty on Diabetes Type II Patient ComplianceNCT02074540 · 2014-04-01

A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in DiabeticsNCT01713764 · 2012-10-01

A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary CareNCT01121315 · 2010-05-01

Common interventions

American Diabetes Association DietBEHAVIORAL1 Core Strengthening with Diaphragmatic BreathingOTHER1 core strengthening with pilate breathingOTHER1 DermGENBIOLOGICAL1 FulvestrantDRUG1 InavolisibDRUG1 Low Carbohydrate DietBEHAVIORAL1 Mindfulness and Positive Affect SkillsBEHAVIORAL1 Novartis AccessOTHER1 PalbociclibDRUG1 QuestionnaireOTHER1 V-GoDEVICE1

Leading sponsors

AstraZeneca1 Boston University1 Dr. Paul F. Gratzer1 Duke University1 Foundation University Islamabad1 Hillel Yaffe Medical Center1 Hoffmann-La Roche1 University of California, San Francisco1 Valeritas, Inc.1

Trial status mix

COMPLETED5

UNKNOWN2

NOT_YET_RECRUITING1

RECRUITING1

Phase mix

NA2

PHASE22

PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.